We are live on ! Find out more
2Xideas

2Xideas Portfolio holdings

AUM $187M Turnover 22.92%
1-Year Est. Return 16.78%
This Fund
S&P 500
This Quarter Est. Return
+9.04%
1 Year Est. Return
+16.78%
3 Year Est. Return
+68.27%
5 Year Est. Return
+58.1%
10 Year Est. Return
–
AUM
$945M
AUM Growth
-$3.44M
Cap. Flow
-$74.9M
Cap. Flow %
-7.92%
Top 10 Hldgs %
40.42%
Holding
76
New
3
Increased
32
Reduced
31
Closed
10
Avg Time Held
1.6 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$10M
2
HALO icon
Halozyme
HALO
+$9.7M
3
ABCM
Abcam PLC
ABCM
+$9.33M
4
MTCH icon
Match Group
MTCH
+$4.03M
5
ENTG icon
Entegris
ENTG
+$3.38M

Top Sells

Rank Stock Value
1
ST icon
Sensata Technologies
ST
+$15.7M
2
AVLR
Avalara
AVLR
+$11.6M
3
MASI icon
Masimo
MASI
+$9.6M
4
ABMD
Abiomed Inc
ABMD
+$9M
5
CLX icon
Clorox
CLX
+$8.85M

Sector Composition

Rank Sector Weight
1 Healthcare 27.44%
2 Technology 24.64%
3 Financials 20.65%
4 Consumer Discretionary 9.13%
5 Industrials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ICE icon
1
Intercontinental Exchange
ICE
$97.2B
$64.6M 6.84%
629,976
-16,272
-3% -$1.62M
2020 Q4
8 quarters
IQV icon
2
IQVIA
IQV
$40.7B
$62.5M 6.62%
305,234
-16,358
-5% -$3.32M
2020 Q4
8 quarters
RMD icon
3
ResMed
RMD
$33.7B
$58.8M 6.23%
282,719
-16,389
-5% -$3.6M
2020 Q4
8 quarters
ANSS icon
4
DELISTED
Ansys
ANSS
$51.1M 5.41%
211,696
-2,566
-1% -$598K
2020 Q4
8 quarters
SCI icon
5
Service Corp International
SCI
$9.6B
$25.4M 2.69%
367,105
-19,859
-5% -$1.32M
2020 Q4
8 quarters
RVTY icon
6
Revvity
RVTY
$16.4B
$24.8M 2.63%
177,118
-19,358
-10% -$2.6M
2020 Q4
8 quarters
MSCI icon
7
MSCI
MSCI
$45.1B
$24.1M 2.55%
51,757
-3,398
-6% -$1.58M
2020 Q4
8 quarters
HALO icon
8
Halozyme
HALO
$10.6B
$23.7M 2.51%
416,586
+190,115
+84% +$9.7M
2022 Q2
2 quarters
FTNT icon
9
Fortinet
FTNT
$94B
$23.4M 2.48%
479,245
-4,337
-0.9% -$226K
2020 Q4
8 quarters
NYT icon
10
New York Times
NYT
$11.2B
$23.4M 2.47%
719,933
-67,236
-9% -$2.19M
2021 Q2
6 quarters
FAST icon
11
Fastenal
FAST
$60.3B
$22.9M 2.42%
967,000
-15,846
-2% -$387K
2020 Q4
8 quarters
ZBRA icon
12
Zebra Technologies
ZBRA
$14.5B
$22.2M 2.35%
86,769
+642
+0.7% +$166K
2022 Q3
1 quarter
KNSL icon
13
Kinsale Capital Group
KNSL
$8.98B
$21.4M 2.26%
81,742
-13,250
-14% -$3.82M
2021 Q3
5 quarters
PTC icon
14
PTC
PTC
$21.3B
$19.9M 2.11%
166,068
-9,963
-6% -$1.19M
2022 Q3
1 quarter
ISRG icon
15
Intuitive Surgical
ISRG
$141B
$10.8M 1.15%
40,850
-5,660
-12% -$1.38M
2020 Q4
8 quarters
FERG icon
16
Ferguson
FERG
$47.6B
$10.6M 1.12%
83,561
-5,705
-6% -$664K
2022 Q1
3 quarters
MKL icon
17
Markel Group
MKL
$24.1B
$10.6M 1.12%
8,013
+305
+4% +$377K
2020 Q4
8 quarters
TW icon
18
Tradeweb Markets
TW
$27B
$10.5M 1.11%
161,405
+15,308
+10% +$900K
2020 Q4
8 quarters
ULTA icon
19
Ulta Beauty
ULTA
$27B
$10.5M 1.11%
22,336
-1,191
-5% -$514K
2020 Q4
8 quarters
A icon
20
Agilent Technologies
A
$48.7B
$10.4M 1.11%
69,812
-6,614
-9% -$944K
2020 Q4
8 quarters
IT icon
21
Gartner
IT
$11.3B
$10.4M 1.1%
31,051
-5,749
-16% -$1.86M
2020 Q4
8 quarters
COO icon
22
Cooper Companies
COO
$11.4B
$10.4M 1.1%
126,236
-1,068
-0.8% -$78.8K
2021 Q4
4 quarters
EL icon
23
Estee Lauder
EL
$37.1B
$10.4M 1.1%
42,026
+2,846
+7% +$636K
2020 Q4
8 quarters
SBUX icon
24
Starbucks
SBUX
$121B
$10.4M 1.1%
105,093
-11,797
-10% -$1.11M
2020 Q4
8 quarters
VRSN icon
25
VeriSign
VRSN
$28.2B
$10.4M 1.1%
50,609
-3,588
-7% -$688K
2020 Q4
8 quarters

Similar funds

2Xideas's Q4 2022 Portfolio in Review

As of Q4 2022, 2Xideas held 76 positions worth $945M, down 0.36% from $948M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

2Xideas withdrew a net $74.9M in Q4 2022, closing 10 positions and reducing 31 holdings. Its most notable exit was Avalara, an estimated $11.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, 2Xideas opened a new position in Labcorp worth $10.4M.

  • 2Xideas's largest Q4 2022 buy was Labcorp: 51,317 shares worth $10.4M.
  • 2Xideas added most to Halozyme in Q4 2022, an estimated $9.7M increase.
  • 2Xideas's biggest Q4 2022 reduction was Sensata Technologies, cutting an estimated $15.7M.
  • 2Xideas fully exited Avalara in Q4 2022, selling an estimated $11.6M.
  • 2Xideas's ten largest holdings make up 40% of its $945M portfolio in Q4 2022.
  • 2Xideas opened 3 new positions and closed 10 in Q4 2022.
  • 2Xideas's portfolio value fell 0.36% quarter-over-quarter to $945M.

Based on 2Xideas's 13F filing for Q4 2022, filed 14 Feb 2023.